A randomized phase II study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma: A North Central Cancer Treatment Group Study, N0775

BACKGROUND: Increasing evidence shows chemotherapy in combination with VEGF inhibition is a clinically active therapy for patients with metastatic melanoma (MM). METHODS: A phase II trial was conducted in chemotherapy naïve patients with unresectable stage IV MM who were randomized to temozolomide (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kottschade, Lisa A., Suman, Vera J., Perez, Domingo G., McWilliams, Robert R., Kaur, Judith S., Amatruda, Thomas T., Geoffroy, Francois J., Gross, Howard M., Cohen, Peter A., Jaslowski, Anthony J., Kosel, Matthew L., Markovic, Svetomir N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4089063/
https://ncbi.nlm.nih.gov/pubmed/22915053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27760
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados